Guidant's Non-Randomized Ancure AAA Study Acceptable, Panel Concludes
This article was originally published in The Gray Sheet
Executive Summary
Guidant's Ancure tube and bifurcated endovascular graft systems for abdominal aortic aneurysm (AAA) treatment have 19.6% and 28.7% respective rates of operative adverse events compared with 44.1% for surgical repair, according to data from the firm's pivotal clinical trial.